BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27877592)

  • 1. Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems.
    Chen YC; Huang XC; Luo YL; Chang YC; Hsieh YZ; Hsu HY
    Sci Technol Adv Mater; 2013 Aug; 14(4):044407. PubMed ID: 27877592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery.
    Kesse S; Boakye-Yiadom KO; Ochete BO; Opoku-Damoah Y; Akhtar F; Filli MS; Asim Farooq M; Aquib M; Maviah Mily BJ; Murtaza G; Wang B
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advancement of Nanotheranostics in Cancer Applications.
    Parveen S; Abira R; Paikray S; Sahoo L; Tripathy NS; Dilnawaz F
    Curr Drug Deliv; 2024 May; ():. PubMed ID: 38812425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
    Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications.
    Tehrani Fateh S; Moradi L; Kohan E; Hamblin MR; Shiralizadeh Dezfuli A
    Beilstein J Nanotechnol; 2021; 12():808-862. PubMed ID: 34476167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous carbon nanomaterials in drug delivery and biomedical application.
    Zhao Q; Lin Y; Han N; Li X; Geng H; Wang X; Cui Y; Wang S
    Drug Deliv; 2017; 24(sup1):94-107. PubMed ID: 29124979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence resonance energy transfer monitoring of pH-responsive doxorubicin release from carbon dots/aptamer functionalized magnetic mesoporous silica.
    Kajani AA; Mehrgardi MA
    Nanomedicine (Lond); 2021 Apr; 16(8):627-639. PubMed ID: 33759545
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles in biomedical applications.
    Li Z; Barnes JC; Bosoy A; Stoddart JF; Zink JI
    Chem Soc Rev; 2012 Apr; 41(7):2590-605. PubMed ID: 22216418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    Chen D; Dougherty CA; Zhu K; Hong H
    J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
    Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
    J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric multifunctional nanomaterials for theranostics.
    Peng H; Liu X; Wang G; Li M; Bratlie KM; Cochran E; Wang Q
    J Mater Chem B; 2015 Sep; 3(34):6856-6870. PubMed ID: 32262535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.